Pro Share Advisors LLC Chimerix Inc Transaction History

Pro Share Advisors LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$1.67 - $2.35 $9,712 - $13,667	-5,816 Reduced 34.93%	10,834 $20,000
Q3 2022 Nov 04, 2022	BUY	$1.81 - $2.76 $689 - $1,051	381 Added 2.34%	16,650 $32,000
Q2 2022 Aug 01, 2022	SELL	$1.34 - $5.34 $8,597 - $34,261	-6,416 Reduced 28.28%	16,269 $34,000
Q1 2022 May 10, 2022	SELL	$4.58 - $6.8 $25,162 - $37,359	-5,494 Reduced 19.5%	22,685 $103,000
Q4 2021 Feb 08, 2022	BUY	$5.23 - $7.18 $147,376 - $202,325	28,179 New	28,179 $182,000
Q3 2021 Nov 12, 2021	SELL	$5.94 - $8.75 $112,497 - $165,716	-18,939 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$7.54 - $9.79 $22,906 - $29,742	3,038 Added 19.11%	18,939 $152,000
Q1 2021 May 14, 2021	BUY	$4.76 - $11.25 $24,076 - $56,902	5,058 Added 46.65%	15,901 $153,000
Q4 2020 Feb 09, 2021	BUY	$2.43 - $5.42 $26,348 - $58,769	10,843 New	10,843 $52,000
Q4 2018 Feb 14, 2019	SELL	$2.24 - $3.9 $55,946 - $97,406	-24,976 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$3.58 - $4.9 $3,207 - $4,390	-896 Reduced 3.46%	24,976 $97,000
Q2 2018 Aug 13, 2018	SELL	$4.43 - $5.14 $8,567 - $9,940	-1,934 Reduced 6.96%	25,872 $123,000
Q1 2018 May 14, 2018	SELL	$4.65 - $5.9 $20,925 - $26,550	-4,500 Reduced 13.93%	27,806 $145,000
Q4 2017 Feb 14, 2018	BUY	$4.32 - $5.52 $139,561 - $178,329	32,306	32,306 $150,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.